Health Care

4461 posts
Close up of CSL sign on the office building in Melbourne, Victoria, Australia.

CSL profit drop only deepens what has already been grim reporting week

CSL Ltd has backed up its chaotic Tuesday – where the board dumped Paul McKenzie –…

Paradigm Biopharmaceuticals to boost oral treatment of osteoarthritis for animals

Paradigm Biopharmaceuticals (ASX: PAR) is co-developing a novel oral combination therapy for the treatment of osteoarthritis…
MEG scan concept AI gen

Compumedics snags sixth order for Orion LifeSpan at $4.2M heading to Shandong

Compumedics has inked a fresh $4.2M order to kick off CY26 with a sixth unit of…
A woman with a sign and a sad face

Last year’s anti-sweat biotech darling Botanix falls -10% on poorly received quarterly

Botanix Pharma (ASX:BOT) saw its share price fall around -10% on Tuesday as the company’s latest quarterly update, in
Brain scan concept

Healthcare disruptor Compumedics clocks record sales in 1H FY26 at $33M; revenue up +32%

Compumedics has posted its highest-ever sales figure, netting $33M in the first half of FY26, also…
Chinese health market concept

Telix jumps on maiden Chinese application for prostate imaging agent, but short selling increasing

Telix Pharma’s (ASX:TLX) got the Chinese market locked in its sights with a maiden application for Illuccix, a prostate
FDA cpmce[t

Mesoblast dips on confusion around FDA advice on stem cells for back pain

Mesoblast (ASX:MSB) has seen its shares dip on Monday morning out the gate as some investors struggle to digest
Kuala Lumpur skyline

ReNerve jumps as flagship medtech approved in Malaysia, but gains pare in rush hour

ReNerve initially had a strong green run Thursday morning but by rush hour shares had pared…
Man holds Aus notes

4DMedical reportedly raising $150M at $3.80/sh; ASX 200 inclusion possible

4DMedical has startled some HotCopper forum users as it stages a $150 million capital raising at…
FDA Approval

Imricor Medical Systems runs hard on FDA greenlight for diagnostic catheter

Imricor has won its first keystone FDA clearance, with the U.S. regulator effectively thumbs-upping Imricor's diagnostic…